Edward B Touma

Title: Edward B. Touma: Innovator in Nicotinic Acetylcholine Receptor Research

Introduction

Edward B. Touma is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of biochemistry, particularly in the study of nicotinic acetylcholine receptors. With a total of 4 patents to his name, his work has implications for both scientific research and potential therapeutic applications.

Latest Patents

Touma's latest patents include innovations related to the variant human α7 acetylcholine receptor subunit. This invention provides a variant human α7 nicotinic acetylcholine receptor (nAChR) polypeptide, which contains an amino acid substitution at the valine-274 position of the wild-type human α7 nAChR. The patents also detail nucleic acid molecules encoding the variant human α7 nAChR, as well as vectors and host cells that contain such nucleic acid molecules. Furthermore, methods for producing the variant and using it for screening compounds for activity at the nAChR are also included.

Career Highlights

Throughout his career, Edward B. Touma has worked with prominent organizations, including Abbott Laboratories Corporation. His work has been instrumental in advancing the understanding of nicotinic receptors and their potential applications in medicine.

Collaborations

Touma has collaborated with esteemed colleagues such as Clark A. Briggs and Murali Gopalakrishnan. These partnerships have contributed to the depth and breadth of his research endeavors.

Conclusion

Edward B. Touma's innovative work in the field of nicotinic acetylcholine receptors showcases his dedication to advancing scientific knowledge and potential therapeutic solutions. His contributions continue to influence research and development in this critical area of biochemistry.